Firm Observational Clinical Unicenter Study on Guillain Barré Syndrome
NCT04829526 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100
Last updated 2024-12-17
Summary
The aim of this retrospective observational single-center cohort study is to gain a deeper understanding regarding the frequency, the clinical and electrophysiologic characteristics (e.g., the diagnostic work up), complications, treatment regimes, and their associations with specific courses of disease and outcomes in adult patients with the suspected or proven diagnosis of GBS.
Conditions
- Guillain-Barre Syndrome (GBS)
Interventions
- OTHER
-
data collection
Retrospective extraction of demographic, clinical, laboratory, and electrophysiological data from the digital medical records
Sponsors & Collaborators
-
University Hospital, Basel, Switzerland
lead OTHER
Principal Investigators
-
Raoul Sutter, Prof. Dr. med. · Clinic for Intensive Care Medicine, University Hospital Basel
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2021-03-01
- Primary Completion
- 2026-07-31
- Completion
- 2026-07-31
Countries
- Switzerland
Study Locations
More Related Trials
-
Efficacy of Intravenous Gamma Globulin on Guillain-Barre Syndrome
NCT04303962 ·Status: UNKNOWN
-
Prospective Study on Swallowing/Breathing Interactions in Severe Guillain Barre Syndrome.
NCT01024088 ·Status: COMPLETED
-
Living With Guillain-Barré Syndrome as Children.
NCT06940908 ·Status: RECRUITING
-
A Clinical Study of ANX005 and IVIG in Subjects With Guillain Barré Syndrome (GBS)
NCT04035135 ·Status: COMPLETED ·Phase: PHASE1
-
sCD163 as a Potential Biomarker in Guillain- Barré Syndrome
NCT02582853 ·Status: UNKNOWN
-
Multispectral Optoacoustic Imaging for the Detection of Inflammation and Damage of Peripheral Nerves in Guillain-Barré Syndrome and Chronic Inflammatory Demyelinating Polyneuropathy
NCT07121985 ·Status: NOT_YET_RECRUITING
-
Efficacy and Safety of ANX005 in Subjects With Guillain-Barré Syndrome
NCT04701164 ·Status: COMPLETED ·Phase: PHASE3
-
A Study of Imlifidase in Patients With Guillain-Barré Syndrome
NCT03943589 ·Status: COMPLETED ·Phase: PHASE2
-
International Guillain-Barré Syndrome Outcome Study
NCT01582763 ·Status: COMPLETED
-
Inhibition of Complement Activation (Eculizumab) in Guillain-Barre Syndrome Study
NCT02029378 ·Status: UNKNOWN ·Phase: PHASE2
-
Randomized Study of Plasmapheresis or Human Immunoglobulin Infusion in Childhood Guillain-Barre Syndrome
NCT00004833 ·Status: TERMINATED ·Phase: NA
-
Efficacy and Safety Study of GB-0998 for Guillain-Barré Syndrome
NCT02342184 ·Status: COMPLETED ·Phase: PHASE3
-
Comparison of the Efficacy and Safety of Immunoadsorption and Intravenous Immunoglobulin for Guillain-Barre Syndrome
NCT05114941 ·Status: NOT_YET_RECRUITING ·Phase: NA
-
IVIG Versus Plasmapheresis in the Treatment of Guillian Barrie Syndrome Patients
NCT05104762 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
Change of Nerve Conduction Properties in IVIg Dependent Neuropathies
NCT01655394 ·Status: UNKNOWN
-
A Clinical Trial of CK0801 (a New Drug) In Patients With Treatment-Resistant Guillain-Barré Syndrome (GBS)
NCT03773328 ·Status: WITHDRAWN ·Phase: PHASE1
-
Study of the Effectiveness of Intravenous Immune Globulin (10%) for the Treatment of Multifocal Motor Neuropathy
NCT00666263 ·Status: COMPLETED ·Phase: PHASE3
-
A Study Investigating Intravenous Human Normal Immune Globulin (IGIV) 10% in Subjects With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
NCT06752356 ·Status: RECRUITING ·Phase: PHASE3
-
A Study to Evaluate the Efficacy and Safety of Eculizumab in Guillain-Barré Syndrome
NCT04752566 ·Status: COMPLETED ·Phase: PHASE3
-
EVALUATION OF SERUM INFLAMMATORY CYTOKINE CONCENTRATION IN HEREDITARY SENSITIVOMOTOR NEUROPATHIES
NCT06808581 ·Status: COMPLETED ·Phase: NA
-
Mini-pool Intravenous Immunoglobulin (MP-IVIG) in Guillain-Barré Syndrome
NCT04550611 ·Status: UNKNOWN ·Phase: NA
-
A Study to Evaluate the Safety, Tolerability, Efficacy, Pharmacokinetics and Pharmacodynamics of M281 Administered to Adults With Generalized Myasthenia Gravis
NCT03772587 ·Status: COMPLETED ·Phase: PHASE2
-
Study to Test the Safety, Tolerability and Efficacy of UCB7665 in Subjects With Moderate to Severe Myasthenia Gravis
NCT03052751 ·Status: COMPLETED ·Phase: PHASE2
-
RWE-based Treatment Patterns and Outcomes in CIDP
NCT05940922 ·Status: UNKNOWN
-
JET-GBS - Japanese Eculizumab Trial for GBS
NCT02493725 ·Status: COMPLETED ·Phase: PHASE2